Atlas Trials

Safety, PK/PD, and Exploratory Efficacy Study of AMT-191 in Classic Fabry Disease

Clinical trial NCT06270316 · RECRUITING

Trial details

NCT number
NCT06270316
Sponsor
UniQure Biopharma B.V.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Fabry Disease
Start date
2024-06-05
Primary completion
2027-12-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.